RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,515 | +22.0% | 12,505 | 0.0% | 0.00% | – |
| Q2 2023 | $30,762 | -81.6% | 12,505 | -83.1% | 0.00% | – |
| Q1 2023 | $167,048 | -22.1% | 73,915 | +20.4% | 0.00% | – |
| Q4 2022 | $214,321 | -91.8% | 61,410 | -12.9% | 0.00% | -100.0% |
| Q3 2022 | $2,611,000 | +89.6% | 70,515 | -2.7% | 0.00% | – |
| Q2 2022 | $1,377,000 | -23.9% | 72,506 | +8.2% | 0.00% | -100.0% |
| Q1 2022 | $1,809,000 | +76.8% | 66,996 | +47.6% | 0.00% | – |
| Q4 2021 | $1,023,000 | -5.5% | 45,375 | +10.0% | 0.00% | – |
| Q3 2021 | $1,082,000 | -65.9% | 41,257 | -58.4% | 0.00% | -100.0% |
| Q2 2021 | $3,175,000 | -4.7% | 99,167 | +4.9% | 0.00% | 0.0% |
| Q1 2021 | $3,330,000 | +11.9% | 94,562 | +1.9% | 0.00% | 0.0% |
| Q4 2020 | $2,977,000 | -11.5% | 92,828 | +3.8% | 0.00% | -50.0% |
| Q3 2020 | $3,365,000 | -16.5% | 89,436 | -0.7% | 0.00% | 0.0% |
| Q2 2020 | $4,031,000 | +121.5% | 90,056 | +68.9% | 0.00% | +100.0% |
| Q1 2020 | $1,820,000 | -5.2% | 53,328 | +8.4% | 0.00% | 0.0% |
| Q4 2019 | $1,919,000 | – | 49,187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |